Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial
|Ava K Bittner1,4, Sheryl Torr-Brown2, Ellen Arnold1, Antonia Nwankwo1, Patricia Beaton2, Radhika Rampat3, Gislin Dagnelie1 and Mark Roser2|
|1Johns Hopkins Wilmer Eye Institute, 600 N. Wolfe St., Baltimore, MD 21287, USA|
|2KeepSight, 515 Old Slocum Rd, Hebron, CT 06248, USA|
|3Moorefields Eye Hospital, London, UK|
|4Nova Southeastern University, College of Optometry, 3200 South University Dr., Ft. Lauderdale, FL, 33328-2018, USA|
|Corresponding Author :||Ava Bittner
Nova Southeastern University
College of Optometry, 3200 South University Dr
Ft. Lauderdale, FL 33328-2018, USA
E-mail: [email protected]
|Received: December 17, 2013; Accepted: January 15, 2014; Published: January 22, 2014|
|Citation: Bittner AK, Torr-Brown S, Arnold E, Nwankwo A, Beaton P, et al. (2014) Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial. J Clin Exp Ophthalmol 5:320. doi:10.4172/2155-9570.1000320|
|Copyright: © 2014 Bittner AK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at
Pubmed Scholar Google
Objective: An educational, interactive journal [Vision and Memory Stimulating (VMS) journal] was developed to boost patient confidence and promote long-term adherence with weekly vision self-monitoring in age-related macular degeneration (AMD) patients at risk for vision loss from new-onset neovascularization.
Methods: In a multicenter randomized controlled trial, 198 subjects with intermediate stage, non-neovascular AMD received the VMS journal or followed usual care (e.g. their doctor’s instructions for vision monitoring; Amsler grid). At 6 and/or 12 months post-enrollment, 157 subjects completed a questionnaire on vision self-monitoring.
Results: At 6 and 12 months, respectively, 85% and 80% of the VMS journal subjects reported vision monitoring at least weekly, which represent statistically significant 7.1 and 4.2 times greater odds than the 50% of controls who monitored weekly at both follow-up times (p<0.001). At 6 and 12 months, respectively, 29% and 25% of controls indicated that they had not checked their vision in the past 6 months, while only 1.5% and 5% of the VMS journal subjects reported no vision self-monitoring. At 6 and 12 months, respectively, only 15% and 13% of the VMS journal subjects vs. 53% and 44% of the controls reported that they did not feel confident that they were taking care of their sight by self-monitoring (p<0.001). Usual care controls had statistically significant 6.7 and 5.0 times greater odds of reporting non-confidence at 6 and 12 months, respectively. There was no statistically significant change in weekly vs. less frequent self-monitoring between the groups (p=0.68), with 81% of all subjects reporting no change in frequency between 6 and 12 months.
Conclusions: These findings support the efficacy of the VMS journal for increasing vision self-monitoring adherence and confidence, in addition to promoting persistence in weekly monitoring over the course of a year in AMD subjects at risk for exudative retinal changes.